BioGalen Pharmaceuticals

Cardiovascular and Diabetes Generic Manufacturer and Exporter

Therapeutic Area · Antihypertensives, Antidiabetics, Statins · WHO-GMP Certified

BioGalen Pharmaceuticals is a WHO-GMP certified manufacturer and exporter of cardiovascular and antidiabetic generic medicines, supplying the chronic-disease treatments behind rising non-communicable disease demand to importers, distributors, government tender suppliers, and health programmes across Africa and beyond. Our range covers antihypertensives, lipid-lowering agents, antidiabetics, and antiplatelet medicines.

Our Cardiovascular and Diabetes Range

  • Antidiabetics: Metformin, Metformin-Gliclazide, Glibenclamide
  • Antihypertensives: Amlodipine, Losartan, Atenolol, Enalapril, Lisinopril, Nifedipine, Losartan-Hydrochlorothiazide
  • Lipid-lowering: Atorvastatin
  • Antiplatelet / cardiac: Clopidogrel, Aspirin
  • Diuretics: Furosemide, Amiloride, Amiloride-Hydrochlorothiazide

Meeting Rising NCD Demand in Africa

Non-communicable diseases, including hypertension, diabetes, and cardiovascular disease, are rising rapidly across African markets, driving sustained and growing demand for chronic medicines. As these are taken long-term, they represent steady, repeat-order demand for distributors and a priority for national essential-medicines supply. We manufacture these treatments under WHO-GMP with CTD and ACTD dossiers for registration. Learn more about what WHO-GMP certification means.

Supplying Importers, Distributors and Tenders

We supply cardiovascular and antidiabetic medicines to importers, distributors, government tenders, and health programmes, with competitive volume pricing, flexible packaging, private labelling, and full regulatory documentation.

Frequently Asked Questions

What cardiovascular and diabetes medicines does BioGalen manufacture?
BioGalen manufactures antidiabetics (Metformin, Glibenclamide, Metformin-Gliclazide), antihypertensives (Amlodipine, Losartan, Atenolol, Enalapril, Lisinopril, Nifedipine), lipid-lowering Atorvastatin, antiplatelet Clopidogrel and Aspirin, and diuretics including Furosemide, all under WHO-GMP.
Does BioGalen supply chronic-disease medicines for African markets?
Yes. BioGalen supplies cardiovascular and antidiabetic generics to importers, distributors, government tenders, and health programmes across Africa, where non-communicable disease demand is rising, with CTD and ACTD dossiers for registration.

Request a Cardiovascular & Diabetes Quote

Tell us the products, strengths, and volumes you need, and we will respond with pricing and supply terms.